Tenascin-C and Its Role in Osteoarthritis
Author Information
Author(s): Lisha Patel, Weiyong Sun, Sonya S. Glasson, Elisabeth A. Morris, Carl R. Flannery, Priya S. Chockalingam
Primary Institution: Pfizer, Cambridge, MA, USA
Hypothesis
Does Tenascin-C induce inflammatory mediators and matrix degradation in osteoarthritic cartilage?
Conclusion
Elevated levels of Tenascin-C in osteoarthritis patients could induce inflammatory mediators and promote matrix degradation in joints.
Supporting Evidence
- Tenascin-C expression was significantly upregulated in OA cartilage.
- IL-1 enhanced Tenascin-C expression in articular cartilage.
- Addition of Tenascin-C induced IL-6, PGE2, and nitrate release in chondrocytes.
- Tenascin-C treatment resulted in increased proteoglycan loss from cartilage explants.
- A correlation was observed between Tenascin-C and aggrecanase generated ARG-aggrecan fragment levels.
Takeaway
Tenascin-C is a protein that increases in osteoarthritis and can cause inflammation and damage to cartilage in the joints.
Methodology
The study analyzed Tenascin-C expression in human cartilage and evaluated its effects on inflammatory mediators and proteoglycan loss using chondrocyte cultures and synovial fluid samples.
Potential Biases
Potential bias due to the involvement of authors from Pfizer, which may influence the study's outcomes.
Limitations
The study primarily focused on human samples and may not fully represent other populations or conditions.
Participant Demographics
8 OA patients (4 males, 4 females; ages 50-83) and 8 healthy reference subjects (5 males, 3 females; ages 45-56).
Statistical Information
P-Value
0.0006
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website